When RT is combined with immune checkpoint inhibitors (ICIs), it can potentiate the synergistic effects, where RT contributes to the normalization of the tumor vascular system, enhance the expression of leukocyte adhesion molecules on endothelial cells, and stimulate the secretion of chemokines that attract CD8+ T cells [122]. This evidence concerns the gene CD8A and neoplasm.